BERWYN, PA — AscellaHealth recently released its Q3 2023 Specialty & Rare Pipeline Digest™, a comprehensive quarterly resource of new, pending and upcoming Specialty and Rare Disease drug launches and cell and gene therapies, biosimilars and generics. This complimentary, digital source of industry information supports the specialty drug market needs of all stakeholders and decision-makers including pharmaceutical manufacturers, payers and providers, with essential updates on products that may impact millions of individuals living with or affected by rare disease or complex, chronic conditions.
“As the specialty drug pipeline continues to grow year-over-year, our dedication to providing industry stakeholders with critically important and timely updates remains paramount,” says Andy Szczotka, PharmD, chief pharmacy officer, AscellaHealth. “This latest edition of our Q3 2023 Specialty & Rare Pipeline Digest™ exemplifies our commitment to being at the forefront of disseminating and sharing knowledge, providing valuable insights and data to support our partners, clients, and the entire specialty pharmaceutical ecosystem.”
Dea Belazi, president & CEO, AscellaHealth, adds, “We are proud to provide The Q3 2023 Specialty & Rare Pipeline Digest™ that underscores our mission to support patients and clients with deep industry expertise to drive decision making. We applaud the relentless efforts of pharmaceutical manufacturers in developing and introducing these groundbreaking therapies. Our collaboration with all stakeholders ensures that these advancements translate into improved treatment access, patient care and outcomes.”
AscellaHealth is a single-source partner providing end-to-end, global solutions which result in the streamlined commercialization of specialty drugs, cost savings for clients and an optimal treatment journey for the rare disease / specialty population. Core Services include:
- Pre-Commercialization & Market Access
- Exclusive Distribution, Wholesale, and 3PL Services
- International Specialty Pharmacy Fulfillment including Limited Distribution Drugs
- Comprehensive HUB and Patient Support Services
- Custom Compliance and Persistency Programs
- Streamlined Prior Authorizations
- Technology-based Patient Engagement
- Integrated Copay and Financial Assistance Programs
- Real-time Rx Data and Analytics
- Specialty Pharmacy & Medical Benefit Management
Access the Q3 2023 Specialty & Rare Pipeline Digest™ here.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.